In a cross-sectional study of aPL-positive patients with connective tissue disease and APS, a logistic regression analysis demonstrated the reduced risk of a thrombotic event by taking LDA and/or HCQ [60]. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.